A carregar...

Treatment of secondary hyperparathyroidism in kidney disease: what we know and do not know about use of calcimimetics and vitamin D analogs

There is a growing understanding of the pathophysiology of secondary hyperparathyroidism (SHPT) and a recent emergence of new agents for SHPT treatment in patients with advanced kidney disease. At the same time, appreciation that mineral metabolic derangements promote vascular calcification and cont...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wetmore, James B, Quarles, L Darryl
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3108756/
https://ncbi.nlm.nih.gov/pubmed/21694914
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!